We are analyzing how well sacituzumab govitecan works for patients with advanced breast cancer. The study will also assess safety and explore biomarkers that may predict treatment response.
Health conditions and diseases that the clinical trial is designed to study and treat.
This condition refers to breast cancer that is locally advanced or has spread to other parts of the body, specifically in hormone receptor-positive (HR+) and HER2-negative cases. It typically affects adult men and women, particularly those who are pre or post-menopausal, and is resistant to endocrine therapy and CDK4/6 inhibitors.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.